Literature DB >> 25975189

Comprehensive analysis of factors impacting risks and outcomes of therapy-related myeloid neoplasms following breast cancer treatment.

K Sevcikova1, Z Zhuang2, G Garcia-Manero3, R H Alvarez4, H M Kantarjian3, M Mego5, C Albarracin6, G Tang2, S S Strom7, L J Medeiros2, G N Hortobagyi4, J M Reuben2, J D Khoury2.   

Abstract

Entities:  

Mesh:

Year:  2015        PMID: 25975189     DOI: 10.1038/leu.2015.122

Source DB:  PubMed          Journal:  Leukemia        ISSN: 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  13 in total

1.  Revised international prognostic scoring system for myelodysplastic syndromes.

Authors:  Peter L Greenberg; Heinz Tuechler; Julie Schanz; Guillermo Sanz; Guillermo Garcia-Manero; Francesc Solé; John M Bennett; David Bowen; Pierre Fenaux; Francois Dreyfus; Hagop Kantarjian; Andrea Kuendgen; Alessandro Levis; Luca Malcovati; Mario Cazzola; Jaroslav Cermak; Christa Fonatsch; Michelle M Le Beau; Marilyn L Slovak; Otto Krieger; Michael Luebbert; Jaroslaw Maciejewski; Silvia M M Magalhaes; Yasushi Miyazaki; Michael Pfeilstöcker; Mikkael Sekeres; Wolfgang R Sperr; Reinhard Stauder; Sudhir Tauro; Peter Valent; Teresa Vallespi; Arjan A van de Loosdrecht; Ulrich Germing; Detlef Haase
Journal:  Blood       Date:  2012-06-27       Impact factor: 22.113

2.  Evolving risk of therapy-related acute myeloid leukemia following cancer chemotherapy among adults in the United States, 1975-2008.

Authors:  Lindsay M Morton; Graça M Dores; Margaret A Tucker; Clara J Kim; Kenan Onel; Ethel S Gilbert; Joseph F Fraumeni; Rochelle E Curtis
Journal:  Blood       Date:  2013-02-14       Impact factor: 22.113

3.  NCCN Clinical Practice Guidelines Acute myeloid leukemia.

Authors:  Margaret R O'Donnell; Camille N Abboud; Jessica Altman; Frederick R Appelbaum; Daniel A Arber; Eyal Attar; Uma Borate; Steven E Coutre; Lloyd E Damon; Salil Goorha; Jeffrey Lancet; Lori J Maness; Guido Marcucci; Michael M Millenson; Joseph O Moore; Farhad Ravandi; Paul J Shami; B Douglas Smith; Richard M Stone; Stephen A Strickland; Martin S Tallman; Eunice S Wang; Maoko Naganuma; Kristina M Gregory
Journal:  J Natl Compr Canc Netw       Date:  2012-08       Impact factor: 11.908

4.  Clinical relevance of cancer stem cells in bone marrow of early breast cancer patients.

Authors:  A Giordano; H Gao; E N Cohen; S Anfossi; J Khoury; K Hess; S Krishnamurthy; S Tin; M Cristofanilli; G N Hortobagyi; W A Woodward; A Lucci; J M Reuben
Journal:  Ann Oncol       Date:  2013-06-24       Impact factor: 32.976

Review 5.  Association between diabetes mellitus and breast cancer risk: a meta-analysis of the literature.

Authors:  Shichong Liao; Jinxin Li; Wen Wei; Lijun Wang; Yimin Zhang; Juanjuan Li; Changhua Wang; Shenrong Sun
Journal:  Asian Pac J Cancer Prev       Date:  2011

6.  Outcome of allo-SCT for women with MDS or AML occurring after breast cancer therapy.

Authors:  P Armand; H T Kim; E Mayer; C S Cutler; V T Ho; J Koreth; E P Alyea; J H Antin; R J Soiffer
Journal:  Bone Marrow Transplant       Date:  2010-02-15       Impact factor: 5.483

7.  Cytogenetic findings in blastoid mantle cell lymphoma.

Authors:  Joseph D Khoury; Filiz Sen; Lynne V Abruzzo; Kimberly Hayes; Armand Glassman; L Jeffrey Medeiros
Journal:  Hum Pathol       Date:  2003-10       Impact factor: 3.466

8.  Body mass index, serum sex hormones, and breast cancer risk in postmenopausal women.

Authors:  T J Key; P N Appleby; G K Reeves; A Roddam; J F Dorgan; C Longcope; F Z Stanczyk; H E Stephenson; R T Falk; R Miller; A Schatzkin; D S Allen; I S Fentiman; T J Key; D Y Wang; M Dowsett; H V Thomas; S E Hankinson; P Toniolo; A Akhmedkhanov; K Koenig; R E Shore; A Zeleniuch-Jacquotte; F Berrino; P Muti; A Micheli; V Krogh; S Sieri; V Pala; E Venturelli; G Secreto; E Barrett-Connor; G A Laughlin; M Kabuto; S Akiba; R G Stevens; K Neriishi; C E Land; J A Cauley; L H Kuller; S R Cummings; K J Helzlsouer; A J Alberg; T L Bush; G W Comstock; G B Gordon; S R Miller; C Longcope
Journal:  J Natl Cancer Inst       Date:  2003-08-20       Impact factor: 13.506

9.  Statin use, hyperlipidaemia, and the risk of breast cancer.

Authors:  J A Kaye; C R Meier; A M Walker; H Jick
Journal:  Br J Cancer       Date:  2002-05-06       Impact factor: 7.640

10.  Role of TP53 mutations in the origin and evolution of therapy-related acute myeloid leukaemia.

Authors:  Terrence N Wong; Giridharan Ramsingh; Andrew L Young; Christopher A Miller; Waseem Touma; John S Welch; Tamara L Lamprecht; Dong Shen; Jasreet Hundal; Robert S Fulton; Sharon Heath; Jack D Baty; Jeffery M Klco; Li Ding; Elaine R Mardis; Peter Westervelt; John F DiPersio; Matthew J Walter; Timothy A Graubert; Timothy J Ley; Todd Druley; Daniel C Link; Richard K Wilson
Journal:  Nature       Date:  2014-12-08       Impact factor: 49.962

View more
  3 in total

Review 1.  Clonal hematopoiesis in cancer.

Authors:  Soo J Park; Rafael Bejar
Journal:  Exp Hematol       Date:  2020-02-07       Impact factor: 3.084

2.  Risk of Hematologic Malignant Neoplasms after Postoperative Treatment of Breast Cancer.

Authors:  Marie Joelle Jabagi; Anthony Goncalves; Norbert Vey; Thien Le Tri; Mahmoud Zureik; Rosemary Dray-Spira
Journal:  Cancers (Basel)       Date:  2019-09-29       Impact factor: 6.639

3.  The risk of developing acute non-lymphocytic leukemia in women with breast cancer.

Authors:  Zhong Wang; Zhiyu Li; Qi Wu; Si Sun; Juanjuan Li; Dongcheng Gao; Yimin Zhang; Shengrong Sun
Journal:  Transl Cancer Res       Date:  2020-04       Impact factor: 1.241

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.